acetylleucyl-leucyl-norleucinal and ovalbumin

acetylleucyl-leucyl-norleucinal has been researched along with ovalbumin in 1 studies

Compound Research Comparison

Studies (acetylleucyl-leucyl-norleucinal)	Trials (acetylleucyl-leucyl-norleucinal)	Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal)	Studies (ovalbumin)	Trials (ovalbumin)	Recent Studies (post-2010) (ovalbumin)
321	0	53	19,565	63	5,664

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clark, K; Dick, L; Goldberg, AL; Gramm, C; Hwang, D; Rock, KL; Rothstein, L; Stein, R	1

Other Studies

1 other study(ies) available for acetylleucyl-leucyl-norleucinal and ovalbumin

Article	Year
Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell, 1994, Sep-09, Volume: 78, Issue:5 Topics: Amino Acid Sequence; Animals; Antigen Presentation; B-Lymphocytes; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Histocompatibility Antigens Class I; Leupeptins; Lymphocytes; Mice; Molecular Sequence Data; Multienzyme Complexes; Ovalbumin; Protease Inhibitors; Proteasome Endopeptidase Complex; T-Lymphocytes; Ubiquitins	1994

Article

Year

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

Cell, 1994, Sep-09, Volume: 78, Issue:5

Topics: Amino Acid Sequence; Animals; Antigen Presentation; B-Lymphocytes; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Histocompatibility Antigens Class I; Leupeptins; Lymphocytes; Mice; Molecular Sequence Data; Multienzyme Complexes; Ovalbumin; Protease Inhibitors; Proteasome Endopeptidase Complex; T-Lymphocytes; Ubiquitins

1994